(NASDAQ: JAGX) Jaguar Health's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 53.83%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 59.2%.
Jaguar Health's earnings in 2025 is -$37,742,000.On average, 1 Wall Street analyst forecast JAGX's earnings for 2025 to be -$24,304,473, with the lowest JAGX earnings forecast at -$24,304,473, and the highest JAGX earnings forecast at -$24,304,473.
In 2026, JAGX is forecast to generate -$11,444,339 in earnings, with the lowest earnings forecast at -$11,444,339 and the highest earnings forecast at -$11,444,339.